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Abstract
Background: People tend to feel better after exposure to ultraviolet (UV) radiation. This study
was performed to investigate the impact of UVA exposure on psychological and neuroendocrine
parameters.
Methods: Fifty-three volunteers were separated into 42 individuals who had UVA exposure and
11 individuals who had no UVA exposure. The UVA-exposed volunteers had irradiation sessions
six times in a three-week period. All volunteers completed two questionnaires at baseline (T1) and
at the end of the study (T3). For the determination of serotonin and melatonin serum levels of all
volunteers blood samples were collected at baseline (T1), after the first UVA exposure (T2), and
at the end of the study after the sixth exposure (T3).
Results:  UVA-exposed volunteers felt significantly more balanced, less nervous, more
strengthened, and more satisfied with their appearance at T3. By contrast, the controls did not
show significant changes of psychological parameters. In comparison to T1 and T3, serum serotonin
was significantly higher and the serum melatonin was significantly lower for the volunteers exposed
to UVA at T2. Both, for exposed and non-exposed volunteers serotonin and melatonin levels did
not significantly differ at T1 and T3.
Conclusions: It remains obscure, whether the exposure to UVA or other components of the
treatment were responsible for the psychological benefits observed. The changes of circulating
neuroendocrine mediators found after UVA exposure at T2 may be due to an UVA-induced effect
via a cutaneous pathway. Nevertheless, the positive psychological effects observed in our study
cannot be attributed to circulating serotonin or melatonin.
Background
Despite the well-known risks linked with ultraviolet (UV)
overexposure, use of artificial sunlamp for recreational
and cosmetic purposes has become popular in recent dec-
ades. In addition to the cosmetic effect of tanning, people
feel more active, more energetic and healthier after expo-
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sure to sunlight or artificial UV radiation [1–6]. In an
open study, 840 (83%) sunbed users (n = 1013) reported
being relaxed while using a sunbed [7]. The author specu-
lated on a possible effect on the central nervous system.
However, the apparent psychological benefits were closely
related to the degree of tan that was achieved through the
sunbed and it may be that those subjects who obtained
the desired tan were naturally satisfied with the outcome
[7,8]. In a small number of studies the influence of UV ra-
diation on psychological parameters and/or neuroendo-
crine mediators (e.g., β -endorphin, enkephalin) has been
investigated systematically [6,9–13]. The results of these
studies are controversial, however. Other neuroendocrine
mediators such as serotonin and melatonin could also
play an important role in mediating UV-induced central
effects.
About a quarter of healthy subjects report that winter
weather or cloudy days influence their mood, and about
40% of depressed patients show seasonality, as depressive
periods are limited to either winter or summer months.
These patients respond favorable to light therapy [14–16].
It has been shown that blood serotonin increases in
healthy subjects and patients with non-seasonal depres-
sion after repeated visible light exposure. Therefore, the
involvement of serotonergic mechanisms following light
therapy has been suggested [16]. Serotonin is a hormone
and neurotransmitter. Centrally produced serotonin af-
fects emotional states, appetite, sleep-wake cycles, and
other human rhythms. Peripherally, serotonin is predom-
inantly produced by gastrointestinal tract myenteric plex-
us neurons. It contributes to hemostasis,
immunomodulation, and perception of pain and itch
[16–21].
Much of the serotonin in the pineal gland is converted
into melatonin by serotonin-N-acetyltransferase which is
directly under adrenergic control of sympathetic nerves
and has a strong circadian rhythm of activity. Serotonin as
well as melatonin have serum half-lives less than one
hour [22,23]. Once melatonin is synthesized, it is not
stored in the gland, but is circulated. Secretion of mela-
tonin depends on a circadian rhythm with low levels dur-
ing the day, medium levels in the evening and maximum
levels at night between 2 and 4 a.m.. Apart from modula-
tion of immunobiological defence reactions and aging,
melatonin participates in the regulation of seasonal bio-
logical rhythm. The visible light-induced suppression of
nocturnal melatonin via the eye-brain mechanism has
been documented in a variety of mammalian species, in-
cluding monkeys and humans. In contrast, serotonin is
increased in the retina, pineal gland, and the hypothala-
mus in the presence of visible light [24,25].
We conducted a two-group randomized controlled study
with healthy subjects in order to investigate the impact of
UVA exposure on psychological parameters and serotonin
and melatonin serum levels.
Material and methods
Subjects and study protocol
The three-week study was performed in a university set-
ting during the winter months from December 2000 to
March 2001. Fifty-three healthy volunteers were recruited
and gave their informed consent for participation in the
study. Detailed data of the volunteers are listed in Table 1.
Before the experiments, all volunteers were interviewed
and skin types were determined according to Fitzpatrick's
classification [26]. Exclusion criteria included: history of
regular sunbed use, photosensitivity and psychiatric disor-
ders, drug use and abuse, and UV exposure for two
months prior to the study. Based on unbalanced randomi-
zation the 53 volunteers were separated into 42 individu-
als who had UVA exposures and 11 individuals who had
no UVA exposure in the course of the study.
At baseline (T1), all volunteers (n = 53) completed the
questionnaires and underwent blood collection. Subse-
quently, the exposed volunteers had UVA irradiation (skin
type II: 15 min.; skin type III: 20 min.). After that, blood
collection was performed again (T2). Within the follow-
ing three weeks the exposed volunteers had two UVA irra-
diation sessions on a weekly basis (exposure six times in
total). On the last day of the study (after the sixth UVA ex-
posure) all volunteers completed the questionnaires and
underwent blood collection again (T3).
Table 1: Demographic data of the 53 volunteers, distribution of skin types, and results of colorimetry at T1 and T3
Volunteers (n = 53) Gender female (f), male (m) Mean age ± SD years (range) Skin type Colorimetry L*-values
II III T1 T3
UVA-exposed (n = 42) 32 f, 10 m 25.9 ± 8 (18–57) 18 24 62.7 60.1a
Non-exposed (n = 11) 7 f,4 m 26.5 ± 6.2 (18–36) 3 8 61.4 62.4b
a P < 0.001; b P > 0.05; differences in gender and age between UVA-exposed and non-exposed volunteers were insignificant (P > 0.05)BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/6
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Questionnaires
To assess changes of emotional states and physical aware-
ness of the volunteers at T1 and T3, two well-established
validated questionnaires were employed: Basler Befindli-
chkeits-Skala BBS [27], Fragebogen zum Körperbild FKB-
20 [28]. The BBS (16 items) was developed to assess and
quantify changes of emotional states [factor analysis in-
cludes four factors: 1) vitality 2) intrapsychological home-
ostasis 3) social extroversion 4) vigilance]. The FKB-20
(20 items) was designed to assess non-clinical disturbanc-
es of physical awareness. It measures two independent di-
mensions: 1) negative physical awareness 2) vital physical
dynamics.
UV sources and dosimetry
The Ergoline Classic 450 Super Power sunbed (JK-Prod-
ucts GmbH, Windhagen, Germany) was used for whole-
body irradiation. This air-conditioned tanning device was
fitted with 42 Solarium Plus R1-12-100 W fluorescence
lamps (Wolff System AG, Riegel, Germany). Before the be-
ginning of the investigation, the spectral output of the
lamps was measured with a calibrated MED 2000 spectro-
radiometer (Opsira GmbH, Weingarten, Germany). The
integrated irradiance assessed spectroradiometrically at
skin level was 17.5 mW/cm2 for UVA (means from 16
measure sites). Only a small fraction of UVB was meas-
ured (0.09 mW/cm2). Therefore the fluorescence lamp
was defined as a UVA source. The emission spectrum of
the fluorescence lamp is shown in Figure 1. UVA irradi-
ance was routinely measured each exposure session with
the UV-METER radiometer (Waldmann, Willingen-Sch-
wenningen, Germany). Before each UVA dosimetry and
exposure session the lamps underwent a warm-up period
of 10 min [29]. The UVA dosage of each exposure session
was 16 J/cm2 (skin type II) and 21 J/cm2 (skin type III), re-
spectively. The dosage was given in line with the manufac-
turer's recommendations. The cumulative UVA doses
were 96 J/cm2 for skin type II and 126 J/cm2 for skin type
III. During sunbed exposure the volunteers wore goggles
that were opaque to UV and visible light.
Skin color measurements
To quantify the degree of tanning a compact tristimulus
colorimeter Minolta Chroma Meter CR-200 was em-
ployed (Minolta, Osaka, Japan). The measurements were
performed in accordance with the definitions of the CIE
L* a* b* color space [30]. The luminance (L*) was used to
evaluate differences between skin color of all volunteers
(n = 53) at T1 and T3. The L* value expresses the relative
brightness of the color, ranging from total black to com-
pletely white. Skin color was measured on the forehead.
Serotonin and melatonin serum levels
Blood was collected by venipuncture between 8.00 and
11.00 a.m. after an overnight fast. We saw to it that blood
collection at T1 and T3 was performed at the same time
for the same volunteer. The serum for the serotonin and
melatonin determination was obtained from blood stored
for 60 min and centrifugated for 6 min at 3000 ×  g; after
that, 6 ml serum were stored at -71°C. Serotonin was ana-
lyzed with the enzyme-linked immunosorbent assay ac-
cording to manufacturer's instructions (IBL GmbH,
Hamburg, Germany). The assay procedure is based on the
competition between biotinylated and non-biotinylated
antigen for a fixed number of antibody binding sites.
Bound anti-biotin serotonin is complexed with goat anti-
biotin conjugated to alkaline phosphatase. The cross reac-
tivity of the anti-N-acetylserotonin antiserum against se-
rotonin is less than 0.01%. The lowest detectable level
that can be distinguished from zero standard is 0.03 ng/
ml. This technique has a mean intra-assay variance coeffi-
cient of about 5% and a mean inter-assay variance coeffi-
cient of 7.6%. The results were expressed as the
concentration of serotonin in ng/ml (normal range: 20–
240 ng/ml) [31]. Serum melatonin levels were deter-
mined by means of a commercial radioimmunoassy kit
RIA (IBL GmbH, Hamburg, Germany) that consisted of
125I-melatonin (4 µCi), including antiserum, precipitat-
ing antiserum, serum standards, enzymes, enzyme buffers
and assay buffers. The cross reactivity of the antiserum to
serotonin is less than 0.01%. The lowest detectable level
of melatonin that deviates from the zero standard is < 3.5
ρ g/ml. This technique has a mean intra-assay variance co-
efficient of approximately 8.3% and a mean inter-assay
variance coefficient of about 14.9%. The results were ex-
pressed as the concentration of melatonin in ρ g/ml (nor-
mal range: during day-time up to 30 ρ g/ml and during
night-time up to 150 ρ g/ml) [32].
Figure 1
S p e c t r a l  i r r a d i a n c e  o f  t h e  f l u o r e s c e n c e  l a m p  u s e d  i n  t h i s
study.BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/6
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Statistical analysis
Statistical analysis was performed using SPSS 10.0 for
Windows. Analysis of the distribution was made by the
Kolmogorov-Smirnov-test; to examine the homogeneity
and heterogeneity of variances the Levene's test for equal-
ity of variances was used. After that, the following meth-
ods have been applied: for comparison of two
independent samples by normal distribution: the 2-tailed
Student's t-test for independent samples, for comparison
of two independent samples by non-normal distribution:
the Mann-Whitney U-test (2-tailed), for comparison of
paired samples by normal distribution: the t-test for
paired samples, for comparison of paired samples by non-
normal distribution: the Wilcoxon test. Correlations were
calculated through Pearson's correlation coefficient (r).
The questionnaires were analysed using validated scales
on the basis of factor analysis. P-values of less than 0.05
were considered significant.
Results
The evalution of the BBS questionnaires (questions nos 1,
5, and 6) revealed that UVA-exposed volunteers felt signif-
icantly more balanced (P = 0.01), less nervous (P = 0.03),
and more strengthened (P = 0.009) at T3; the increase of
robustness and strength was confirmed by the results of
the FKB-20 questionnaire (question no. 1). The evalution
of question no. 2 of the FKB-20 questionnaire revealed
that UVA-exposed volunteers were significantly (P = 0.04)
more satisfied with their appearance at T3. Data of the
above-mentioned items with significant changes are pro-
vided in Table 2 and Table 3 in detail. The results of the
other items (detailed data not shown) of the question-
naires completed by the UVA-exposed volunteers showed
no significant differences between T1 and T3 (P > 0.05).
The results of the questionnaires (detailed data not
shown) completed by the controls at T1 and T3 differed
insignificantly (P > 0.05).
The serotonin (normally distributed) and melatonin
(non-normally distributed) serum levels are detailed in
Table 4. In comparison to T1 and T3, serotonin levels of
the UVA-exposed volunteers were significantly higher at
T2 (r = 0.95; P = 0.003 and r = 0.88; P = 0.02, respectively).
The serotonin levels of non-exposed controls differed in-
significantly at T1, T2, and T3. In comparison to T1 and
T3, the melatonin levels were significantly lower for the
Table 2: Data of the BBS questionnaire completed by the UVA-exposed volunteers (n = 42)
Question no. 1 (P = 0.03)
"I feel..." Before UVA exposure (T1) Volunteers (%) After UVA exposure (T3) Volunteers (%)
... very calm. 7(16.7) 9(22)
... calm. 14 (33.3) 18(43.9)
... rather calm. 9(21.4) 10 (24.4)
...equally. 3(7.1) 1 (2.4)
... rather nervous. 6(14.3) 3 (7.3)
... (very) nervous. 3(7.1) 0
Question no. 5 (P = 0.01)
"I feel ..."
... very balanced. 8(19) 11(26.8)
... balanced. 11 (26.2) 16 (39)
...rather balanced. 9(21.4) 7(17.1)
... equally. 7(16.7) 5 (12.2)
... rather unbalanced. 5(11.9) 2 (4.9)
... (very) unbalanced. 2 (4.8) 0
Question no. 6 (P = 0.009)
"I feel..."
... very strengthened. 2 (4.9) 2 (4.9)
... strengthened. 5 (12.2) 11(26.8)
... rather strengthened. 7(17.1) 8(19.5)
...equally. 12 (29.3) 14(34.1)
... rather weakened. 9(22) 5 (12.2)
...(very) weakened. 6(14.7) 2 (2.4)BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/6
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UVA-exposed volunteers at T2 (r = 0.96; P < 0.001 and r =
0.67; P = 0.03). For the non-exposed controls, a signifi-
cantly lower melatonin level was found at T2 versus T1 (r
= 0.94; P = 0.005) but not versus T3. Colorimetric meas-
urements of UVA-exposed volunteers at T3 revealed a sig-
nificant decrease of luminance (P < 0.001), by contrast the
controls showed no significant change of skin color (P >
0.05).
Discussion
The influence of electromagnetic radiation on serotonin
and melatonin serum levels has been predominantly
studied using visible wavelengths that effected via the eye-
brain pathway [4,25,33]. A previous report suggested that
skin light exposure – for example of the popliteal region –
can affect human circadian rhythms and suppress periph-
eral melatonin levels in humans via "humoral pho-
totransduction" [34]. However, subsequent studies have
not supported the existence of extraocular photic regula-
tion of the circadian rhythms in humans [35–37]. To
avoid a possible influence of neuroendocrine effects via
eye-brain mechanism, our volunteers were instructed to
use opaque glasses during irradiation. In comparison to
the high spectral irradiance in the UVA region, the output
within the UVB and visible region was considered negligi-
ble. Thus, we could investigate UVA-induced effects that
were mediated via a cutaneous pathway.
We found a modest increase of serotonin and a decrease
of melatonin levels in the UVA-exposed volunteers at T2.
Both changes were statistically significant (P < 0.001; P <
0.01). At all times, differences of serotonin levels of the
non-exposed controls did not reach significant levels. The
conversion of serotonin to melatonin is a photosensitive
step resulting from the photoinhibition of the enzymes N-
acetyltransferase. It has recently been reported that UVA
Table 3: Data of the FKB-20 questionnaire completed by the UVA-exposed volunteers (n = 42)
Question no. 1 (P = 0.01)
"In all I feel robust and strong" Before UVA exposure (T1) Volunteers (%) After UVA exposure (T3) Volunteers (%)
Not correct or hardly correct 2(5) 1 (2.5)
Correct in part 8(20) 4(10)
Correct to a great extent 26 (65) 29 (72.5)
Absolutely correct 4(10) 6(15)
Question no. 2 (P = 0.04)
"There is something wrong with my appear-
ance"
Not correct or hardly correct 14(34.1) 18(45)
Correct in part 21 (51.2) 19 (47.5)
Correct to a great extent 6(14.6) 3 (7.5)
Absolutely correct 0 0
Table 4: Serotonin and melatonin serum levels* of the UVA-exposed volunteers and non-exposed controls
Serum level T1 T2 T3
Serotonin (ng/ml)
UVA-exposed (n = 42) 215 ± 75.2 228.7 ± 84.2 a 213.2 ± 69.1 d
Non-exposed (n = 11) (191.9 ± 53.7) (198.9 ± 52.4) (212.5 ± 78.5)
Melatonin (ρ g/ml)
UVA-exposed (n = 42) 17.3 ± 15.1 12.5 ± 8b 17.9 ± 20.2 e
Non-exposed (n = 11) (25.7 ± 19.7) (20.6 ± 15.3) c (28.6 ± 41.1)
* Data comprise mean ± SD; a P < 0.001 vs T1; b P = 0.01 vs T1; c P = 0.005 vs T1; d P = 0.02 vs T2; e P 0.03 vs T2BMC Dermatology 2002, 2 http://www.biomedcentral.com/1471-5945/2/6
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radiation is a powerful signal affecting the pineal mela-
tonin-generating system and inhibits N-acetyltransferase
[33,38,39]. Accordingly, it has been observed that
melanocytes are photoresponsive cells which express and
metabolize indolamines, such as melatonin, during the
G2 phase while responding to UV exposure [40]. There-
fore, we make the hypothesis that UVA radiation leads to
an inhibition of N-acetyltransferase via a cutaneous path-
way [41]. As a result the production of serotonin increases
at the expense of melatonin.
Although we observed positive changes in emotional
states and physical awareness for the UVA-exposed volun-
teers, the serum parameters did not correlate with these
changes. Therefore, the mood-modifying effects have
probably not been mediated directly by circulating serot-
onin or melatonin. In contrast to Diffey's report [7] the
psychological benefits observed in our study did correlate
only with slight tan as confirmed by the data of the color-
imetric measurements. However, the UVA-exposed volun-
teers were more satisfied with their appearance at T3 and
therefore possibly felt better (Tab. 3). We cannot rule out
that these psychological benefits were due to the slight tan
that UVA-exposed volunteers experienced. During the last
decades tanning preferences have changed and many peo-
ple consider a slight tan more attractive and healthier than
a deep tan. Of course this trial would have benefited from
a double-blind placebo-controlled study design, as de-
scribed by Polderman et al. [42]. Such a protocol, howev-
er, would be very difficult to attain as the increasing tan of
UVA-exposed subjects would "break the blind" after a few
exposures. Since we intended to investigate the effect of
standard UVA dosage commonly used in tanning salons,
we did the study without a double-blind design. If the
amount of tan would "break the blind" then perhaps a
sunless tanning lotion could be used on UV-exposed as
well as non-exposed individuals. Nevertheless, interac-
tions between the tanning lotion and UV radiation cannot
be ruled out.
It would be interesting to investigate in future studies the
influence of psychosocial effects on emotional states and
physical awareness claimed to occur after UV exposure.
Like, for example, the cognitive theory of the psychologi-
cal effect of the "self-fulfilling-prophecy", in this study
"self-fulfilling-prophecy" could reflect the prevailing
opinion in Western societies that sunlight and sunbed ex-
posure generally improve the mood and emotional states.
Conclusions
Although we observed psychological benefits after a series
of sunbed exposure sessions it has not been possible to
differentiate whether the UVA exposure or other compo-
nents of the treatment; such as the volunteer's knowledge
that he or she was exposed to UVA radiation, and/or the
resultant tan, were responsible for these benefits. The
slight increase in serotonin levels and the decrease in me-
latonin levels of exposed volunteers (T2) may be due to
UVA-induced effects via a cutaneous pathway. Neverthe-
less, the positive psychological effects observed in our
study cannot be attributed to circulating serotonin or me-
latonin. Thus, sophisticated double-blind placebo-con-
trolled trials are necessary to fully elucidate the underlying
mechanisms of mood-modifying effects claimed to be
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